A multiplex diagnostic test kit for nucleic acid detection of SARS-CoV-2, influenza A, and influenza B. This kit enables molecular diagnosis of multiple respiratory pathogens in clinical samples.
Manufactured by
Guangzhou, Guangdong, China
Guangdong Hecin Scientific, Inc. an in-vitro diagnostics (IVD) company with more than 5,000 m2 factory and P2 biosafety laboratory of respiratory pathogens. Hecin has developed the largest biobank and the most comprehensive range of in-vitro diagnosis products of respiratory pathogens in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shenzhen Uni-medica Technology Co., Ltd
China · 6 relevant products
Coyote Bioscience Co.,Ltd
China · 12 relevant products
Nanjing Liming Bio-products Co., Ltd.
China · 2 relevant products
57 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 111 closest product alternatives
Shenzhen Uni-medica Technology Co., Ltd · China
A rapid detection kit for simultaneous qualitative detection of Influenza A, Influenza B, SARS-CoV-2, and Respiratory Syncytial Virus nucleic acids in clinical samples.
Coyote Bioscience Co.,Ltd · China
A diagnostic test kit for the simultaneous detection of SARS-CoV-2 and influenza A and B virus nucleic acids using fluorescence PCR methodology. The kit enables multiplex detection of COVID-19 and influenza in a single assay.
Coyote Bioscience Co.,Ltd · China
A multiplex nucleic acid detection kit for simultaneous identification of SARS-CoV-2 and Type A/B influenza viruses using fluorescent PCR methodology. The kit enables efficient co-screening for COVID-19 and influenza in clinical specimens.
108 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products